Investment
Participated in Khartis Therapeutics' $50M Series B as it emerged from stealth.
Khartis Therapeutics
AUG 13, 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Khartis Therapeutics
Flare Therapeutics